The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Erickson, Gregory F ^a   Shimasaki, Shunichi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; FOLLISTATIN; MESSENGER RNA; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PROTEIN INHIBITOR; BMP15 PROTEIN, RAT; BMP2 PROTEIN, RAT; BMP3 PROTEIN, RAT; BMP4 PROTEIN, RAT; BMP6 PROTEIN, RAT; BMP7 PROTEIN, RAT; BMPR1A PROTEIN, RAT; BMPR1B PROTEIN, RAT; BMPR2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; GDF9 PROTEIN, RAT; GROWTH DIFFERENTIATION FACTOR 9; GROWTH FACTOR RECEPTOR; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; ESTRUS CYCLE; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HISTOGENESIS; IN SITU HYBRIDIZATION; LEYDIG CELL; LUTEAL CELL; LUTEINIZATION; MORPHOGENESIS; NONHUMAN; OOCYTE; OVARY CELL; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; PROTEIN FAMILY; RAT; THECA CELL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIGENE FAMILY; OVARY; OVARY FOLLICLE; OVULATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 3; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; ESTROUS CYCLE; FEMALE; FOLLISTATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH DIFFERENTIATION FACTOR 9; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIGENE FAMILY; OVARIAN FOLLICLE; OVARY; OVULATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; THECA CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4344697192     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-9     Document Type: Article

References (47)

1. Shimasaki S, Moore RK, Erickson GF, Otsuka F: The role of bone morphogenetic proteins in ovarian function. Reproduction, in press.
2. Attisano L, Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243.
3. Takao M, Hino J, Takeshita N, Konno Y, Nishizawa T, Matsuo H, Kangawa K: Identification of rat bone morphogenetic protein-3b (BMP-3b), a new member of BMP-3. Biochem Biophys Res Commun 1996, 219:656-662.
4. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S-I, Ueno N, Sampath K, Chang RJ, Erickson GF: A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci U S A 1999, 96:7282-7287.
5. Lyons KM, Pelton RW, Hogan BL: Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev 1989, 3:1657-1668.
6. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM: The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 1998, 12:1809-1817.
7. Laitinen M, Vuojolainen K, Jaatinen R, Ketola I, Aaltonen J, Lehtonen E, Heikinheimo M, Ritvos O: A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech Dev 1998, 78:135-140.
8. Otsuka F, Yao Z, Lee TH, Yamamoto S, Erickson GF, Shimasaki S: Bone morphogenetic protein-15: Identification of target cells and biological functions. J Biol Chem 2000, 275:39523-39528.
9. Shimasaki S, Koga M, Buscaglia ML, Simmons DM, Bicsak TA, Ling N: Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 1989, 3:651-659.
10. Nakatani A, Shimasaki S, DePaolo LV, Erickson GF, Ling N: Cyclic changes in follistatin gene expression and translation in the rat ovary during the estrous cycle. Endocrinology 1991, 129:603-611.
11. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S: Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 2001, 276:11387-11392.
12. Otsuka F, Moore RK, Shimasaki S: Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 2001, 276:32889-32895.
13. Lee W, Otsuka F, Moore RK, Shimasaki S: The effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 2001, 65:994-999.
14. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk M: Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996, 383:531-535.
15. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL, et al.: Synergistic Roles of Bone Morphogenetic Protein 15 and Growth Differentiation Factor 9 in Ovarian Function. Mol Endocrinol 2001, 15:854-866.
16. Galloway SM, McNatty KP, Cambridge LM, Laitinen MPE, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, et al.: Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000, 25:279-283.
17. Wilson T, Wu X-Y, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O'Connell AR, et al.: Highly Prolific Booroola Sheep Have a Mutation in the Intracellular Kinase Domain of Bone Morphogenetic Protein IB Receptor (ALK-6) That Is Expressed in Both Oocytes and Granulosa Cells. Biol Reprod 2001, 64:1225-1235.
18. Mulsant P, Lecerf F, Fabre S, Schibler L, Monget P, Lanneluc I, Pisselet C, Riquet J, Monniaux D, Callebaut I, et al.: Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc Natl Acad Sci U S A 2001, 98:5104-5109.
19. Souza CJH, MacDougall C, Campbell BK, McNeilly AS, Baird DT: The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene. J Endocrinol 2001, 169:R1-R6.
20. Shimasaki S, Shimonaka M, Zhang H-P, Ling N: Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 1991, 266:10646-10653.
21. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science 1988, 242:1528-1534.
22. Chen D, Feng JQ, Feng M, Harris MA, Mundy GR, Harris SE: Cloning and sequence of bone morphogenetic protein 4 cDNA from fetal rat calvarial cell. Biochim Biophys Acta 1993, 1174:289-292.
23. Ozkaynak E, Schnegelsberg PN, Oppermann H: Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun 1991, 179:116-123.
24. Takeda K, Oida S, Ichijo H, Iimura T, Maruoka Y, Amagasa T, Sasaki S: Molecular cloning of rat bone morphogenetic protein (BMP) type IA receptor and its expression during ectopic bone formation induced by BMP. Biochem Biophys Res Commun 1994, 204:203-209.
25. Beppu H, Minowa O, Miyazono K, Kawabata M: cDNA cloning and genomic organization of the mouse BMP type II receptor. Biochem Biophys Res Commun 1997, 235:499-504.
26. Erickson GF, Nakatani A, Ling N, Shimasaki S: Insulin-like growth factor binding protein-3 gene expression is restricted to involuting corpora lutea in rat ovaries. Endocrinology 1993, 133:1147-1157.
27. Erickson GF, Nakatani A, Ling N, Shimasaki S: Cyclic changes in insulin-like growth factor binding protein-4 (IGFBP-4) mRNA in the rat ovary. Endocrinology 1992, 130:625-636.
28. Erickson GF, Nakatani A, Ling N, Shimasaki S: Localization of insulin-like growth factor-binding protein-5 messenger ribonucleic acid in rat ovaries during the estrous cycle. Endocrinology 1992, 130:1867-1878.
29. Meunier H, Cajander SB, Roberts VJ, Rivier C, Sawchenko PE, Hsueh AJW, Vale W: Rapid changes in the expression of inhibin α-, βA-, and βB- subunits in ovarian cell types during the rat estrous cycle. Mol Endocrinol 1988, 2:1352-1363.
30. Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, Robertson EJ: Mice lacking Bmp6 function. Dev Genet 1998, 22:321-339.
31. Yi SE, LaPolt PS, Yoon BS, Chen JYC, Lu JKH, Lyons KM: The type I BMP receptor BmprIB is essential for female reproductive function. Proc Nat Acad Sci U S A 2001, 98:7994-7999.
32. Erickson GF, Shimasaki S: The role of the oocyte in folliculogenesis. Trends Endocrinol Metab 2000, 11:193-198.
33. Eppig JJ: Oocyte control of ovarian follicular development and function in mammals. Reproduction 2001, 122:829-838.
34. Dooley CA, Attia GR, Rainey WE, Moore DR, Carr BR: Bone morphogenetic protein inhibits ovarian androgen production. J Clin Endocrinol Metab 2000, 85:3331-3337.
35. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C: The ovarian androgen producing cells: A review of structure/function relationships. Endocr Rev 1985, 6:371-399.
36. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, et al.: Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 1992, 267:20352-20362.
37. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995, 9:2795-2807.
38. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995, 9:2808-2820.
39. Otsuka F, Moore RK, Iemura S-I, Ueno N, Shimasaki S: Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 2001, 289:961-966.
40. El-Fouly MA, Cook B, Nekola M, Nalbandov AV: Role of the ovum in follicular luteinization. Endocrinology 1970, 87:288-293.
41. Hubbard GM, Erickson GF: Luteinizing hormone (LH) Independent luteinization and ovulation in hypophysectomized rat: a possible role for the oocyte. Biol Reprod 1988, 39:183-194.
42. Matzuk MM, Finegold MJ, Su J-GJ, Hsueh AJW, Bradley A: -Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 1992, 360:313-319.
43. Matzuk MM, Kumar TR, Shou W, Coerver KA, Lau AL, Behringer RR, Finegold MJ: Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog Horm Res 1996, 51:123-157.
44. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM: Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 1998, 12:96-106.
45. Auersperg N, Wong AST, Choi K-C, Kang SK, Leung PCK: Ovarian surface epithelium: Biology, endocrinology, and pathology. Endocr Rev 2001, 22:255-288.
46. Murdoch WJ, McDonnel AC: Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 2002, 123:743-750.
47. Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, Shimasaki S, Erickson GF: Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J C Endocrinol Metab 2002, 87:1337-1344.